Ignite Creation Date:
2024-05-06 @ 4:04 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02449551
Status:
COMPLETED
Last Update Posted:
2022-06-15
First Post:
2015-05-14
Brief Title:
Study of AZD6094 Volitinib in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-14
First Submit QC Date:
May 17 2015
Study First Post Date:
2015-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-13
Last Update Post Date:
2022-06-15
Last Update Post Date Type:
ACTUAL